Barrier of AI drug discovery

The rise of AI drug discovery has raised hopes of speeding up the development of new drugs. However, many people are unaware that there is a major barrier: only 30% of the small molecule compounds generated by AI can be synthesised. This article introduces the attempts of two ventures to boldly break down that barrier.
https://miyata-bio.net/column/0000395/